Latest news
09.12.2019
DEINOVE and ESPCI Paris obtain funding from the ANR to develop the Deinodrop technology
The Deinodrop technology will be co-developed by ESPCI and DEINOVE to accelerate the discovery and identification of bacteria producing new...
06.12.2019
Evolution in DEINOVE's governance
Emmanuel PETIOT will resign as Chief Executive Officer ("CEO") as of December 31, 2019 Dr. Charles WOLER, Chairman of the Board of...
04.11.2019
New product preview at In-Cosmetics Asia 2019: a second innovative carotenoid from DEINOVE
This new carotenoid has the particularity of absorbing blue light, which is responsible for premature skin ageing, the appearance of skin...
Press Coverage
19.06.2019
DEINOVE among The Top 20 Industrial Biotechnology Companies in Europe
Europe’s industrial biotechnology sector is driving a massive change from petrochemical processes to more sustainable alternatives. Here...
14.06.2019
Formule Verte | Deinove et Avril avancent sur leur nouvelle gamme d’ingrédients
La société de biotechnologies industrielles Deinove et Avril, l’acteur industriel et financier des filières des huiles et des protéines,...
05.06.2019
Zone Bourse | DEINOVE : LCM confirme sa recommandation d'Achat
LCM a confirmé sa recommandation d'Achat et son objectif de cours de 2,7 euros sur Deinove après la signature d'un partenariat avec Dow...